Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for China Pharma Holdings (CPHI) over the last 17 years, with Q3 2025 value amounting to 0.27.

  • China Pharma Holdings' Asset Utilization Ratio fell 3147.4% to 0.27 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.27, marking a year-over-year decrease of 3147.4%. This contributed to the annual value of 0.29 for FY2024, which is 2943.83% down from last year.
  • Latest data reveals that China Pharma Holdings reported Asset Utilization Ratio of 0.27 as of Q3 2025, which was down 3147.4% from 0.31 recorded in Q2 2025.
  • Over the past 5 years, China Pharma Holdings' Asset Utilization Ratio peaked at 0.56 during Q1 2021, and registered a low of 0.27 during Q3 2025.
  • Over the past 5 years, China Pharma Holdings' median Asset Utilization Ratio value was 0.44 (recorded in 2023), while the average stood at 0.43.
  • As far as peak fluctuations go, China Pharma Holdings' Asset Utilization Ratio soared by 2806.62% in 2021, and later crashed by 3147.4% in 2025.
  • Quarter analysis of 5 years shows China Pharma Holdings' Asset Utilization Ratio stood at 0.47 in 2021, then grew by 0.98% to 0.48 in 2022, then dropped by 7.6% to 0.44 in 2023, then dropped by 27.5% to 0.32 in 2024, then decreased by 14.21% to 0.27 in 2025.
  • Its last three reported values are 0.27 in Q3 2025, 0.31 for Q2 2025, and 0.3 during Q1 2025.